What is Cagrilintide used for?
Cagrilintide is most commonly used for users plateaued on Semaglutide or Tirzepatide; people wanting cleaner satiety without bigger GLP-1 nausea; combination-therapy stacks under provider guidance. An appetite-control shot for weight loss. A long-acting amylin agonist that works on a different pathway than the GLP-1 drugs, often paired with Semaglutide as 'CagriSema' to break GLP-1 plateaus. Human evidence for Cagrilintide is limited, so these are the goals people pursue with it, not guaranteed outcomes.
What people use Cagrilintide for
- Users plateaued on Semaglutide or Tirzepatide
- People wanting cleaner satiety without bigger GLP-1 nausea
- Combination-therapy stacks under provider guidance
References
- Once-weekly cagrilintide for weight management, Phase 2 trial — Lau DCW et al., Lancet, 2021
- Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity (REDEFINE 1) — Garvey et al., N Engl J Med, 2025
- Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight management: a randomised, controlled, phase 1b trial — Enebo et al., Lancet, 2021
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Cagrilintide
Full Cagrilintide breakdownCagrilintide side effectsCagrilintide how to take itCagrilintide mistakes to avoidCagrilintide who should avoid itCagrilintide half-lifeCagrilintide how long to workCagrilintide legal statusCagrilintide how it workscagrilintide vs retatrutidesemaglutide vs cagrilintidetirzepatide vs cagrilintideAsk the AI Coach
Last updated 2026-06-15.